HIF-1α and Locally Advanced Breast Cancer
✍ Scribed by Heitor R.C. Marana; Daniel G. Tiezze; Jurandyr M. De Andrade; João S. Da Silva
- Book ID
- 109080047
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 42 KB
- Volume
- 16
- Category
- Article
- ISSN
- 1075-122X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The management of locally advanced breast cancer with single modality therapy has been associated with a high rate of systemic failure. A multimodality treatment strategy that includes induction cytotoxic chemotherapy, surgery, radiation therapy, and, possibly, hormonal ablation therapy is the curre
Thirty-eight patients with locally advanced breast cancer (Stage HI) were treated over a 3-year period. All patients initially received two cycles of CMF (cyclophosphamide, 100 mg/m2 p.0. dl-14; methotrexate 40mg/m2 intravenously (iv), d l and d8., 5 Fluorouracil 500 mg/m2 iv d l and d8). They were